On CNBC’s “Halftime Report Final Trades,” Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he likes AbbVie Inc. (NYSE:ABBV).

Supporting his choice, Canaccord Genuity analyst Gary Nachman maintained AbbVie with a Buy rating on Wednesday and raised the price target from $273 to $282.

Jim Lebenthal, partner and chief market strategist at Cerity Partners, picked Transocean Ltd. (NYSE:RIG) ahead of quarterly earnings.

Transocean will report second quarter earnings and issue a fleet status report on Wednesday, Aug. 5, after the closing bell. Analysts expect the company to report quarterly earnings at 1 cent per share on revenue of $962.88 million.

Don’t forget to check out our premarket coverage here

Malcolm Ethridge, managing partner at Capital Area Planning Group, named Cerebras Systems Inc. (NASDAQ:CBRS) as his final trade.

As per the recent news, CrowdStrike Holdings Inc. (NASDAQ:CRWD) and Cerebras Systems, on Wednesday, announced a strategic partnership to strengthen artificial intelligence-powered cybersecurity.

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, recommended Netflix, Inc. (NASDAQ:NFLX).

On the earnings front, Netflix, on July 16, reported mixed second-quarter financial results and issued weak guidance for the third quarter. Netflix reported second-quarter revenue of $12.56 billion, up 13% year-over-year. The revenue total missed a Street estimate of $12.59 billion, according to data from Benzinga Pro. Second-quarter earnings of 80 cents per share beat a Street consensus estimate of 79 cents per share.

Price Action

• AbbVie shares gained 1.4% to close at $256.92 on Thursday.
• Transocean shares rose 0.4% to settle at $5.32 during the session.
• Cerebras Systems shares surged 4.9% to close at $220.00 on Thursday.
• Netflix shares gained 0.5% to close at $68.89 during the session.

Photo via Shutterstock